A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 29 Jun 2018
At a glance
- Drugs Alicaforsen (Primary)
- Indications Pouchitis
- Focus Registrational; Therapeutic Use
- Sponsors Atlantic Pharmaceuticals
- 29 Jun 2018 According to an Atlantic Healthcare media release, St. Marks Hospital is one of the center for this trial.
- 31 May 2018 This trial has been completed in Netherlands.
- 02 May 2018 According to an Atlantic Healthcare media release, Prof. Brian Feagan, senior scientific director at Robarts clinical trials Inc. is a chief investigator on the study.